Since February this year, thousands of people in Africa have been confirmed to infect by Ebola virus, more than half of them died. This is the largest outbreak of Ebola from 1976, when it was first identified. The international medical aid organization -Doctors Without Borders-recently declared that the epidemic in the relevant countries have been out of control.
Pharmaceutical companies have joined the preparation of drugs to control Ebola virus. Despite the current World Health Organization declares there are still no effective drugs for Ebola, however, a few drugs are currently in clinical trials, and have achieved good results. Now, we sort out these potentially effective drugs
Zmapp, a monoclonal antibody synthetic drug, comes from animals that infected with the Ebola virus. The effectiveness of the drug had been verified by infected macaques. The pharmaceutical company produced only three drugs, two of which were provided to two patients form the United States. This was the first time of the drug used for human beings.
TKM-Ebola, developed by the Canadian pharmaceutical Tekmira, showed a great effect in killing Ebola virus in primates. In August 9, Tekmira shares rose nearly 40 percent.
Ebola vaccine GlaxoSmithKline
The Ebola vaccine developed by GlaxoSmithKline has got positive data in animal experiments, and is currently undergoing Phase I clinical trials.